Kurt Sheline

Principal, Strategic Investment
Kurt Sheline, Echo Health Ventures
Kurt supports Echo Health Ventures in all aspects of the investment process, from deal sourcing and evaluation through transaction management and execution. He is responsible for providing financial and market support that drives investment initiatives and decisions, and the success and growth of Echo’s portfolio of companies.

Kurt currently serves on the boards of Springbuk and Eleanor Health and is a board observer for Octave Bioscience, GNS Healthcare, Quartet Health, and Scipher Medicine. His previous board observer experience includes Circulation prior to its sale to LogistiCare.

Before joining Echo in 2017, Kurt was a Vice President in Cascadia Capital’s Healthcare Technology and Services group, based in Seattle, where he worked closely with management teams in the life sciences, health care technology, and health care services industries, providing business development, positioning, sales & marketing, and transaction advisory and execution services.

Kurt earned a Master of Business Administration from the University of California, Berkeley, and a bachelor’s degree, magna cum laude, in Economics/Pre-Medical Studies from Claremont McKenna College.

Kurt is based out of our Seattle, Washington office.